Experimental Design and Causality: Quick Notes (Caffeine Reaction Time Lab)

Key Concepts

  • Experimental research involves making comparisons between groups; true experiments use random assignment to control groups, while quasi-experiments do not.
  • True experiments vs quasi experiments:
    • True: manipulate the independent variable; compare an experimental group to a control group; random assignment used.
    • Quasi: groups are pre-existing or not randomly assigned; harder to infer causation due to confounds.
  • Association vs causation:
    • Association: a relationship or correlation between variables (e.g., caffeine and reaction time).
    • Causation requires three conditions: association, temporal precedence, and non-spuriousness.
  • Operationalization in the caffeine study: caffeine vs decaf vs nothing measured via reaction time (roller drop task).
  • placebo effect: improvement due to expectation rather than the active treatment; controlled with placebo group (decaf) and blinding.
  • Blinding: reducing bias by concealing group assignment; single, double, and triple blinding vary who is unaware (participants, experimenters, or data analysts).
  • Gold standard: randomized controlled trials (RCTs) with random assignment, placebo controls, and blinding; ideally double blinded.
  • Experimental designs:
    • Between groups (between-subjects): different participants in each condition.
    • Within groups (within-subjects, repeated measures): same participants measured under each condition, with a baseline first measurement.
    • Mixed design: combines between and within features.
  • Baseline measurement: a pre-treatment measure used for comparison in within-subjects or interrupted time series designs.
  • Non-spuriousness: elimination of alternative causes (confounds) via randomization, control groups, blinding.
  • Ethical and practical limits: some causal variables (trauma, brain injury) cannot be manipulated; researchers rely on other designs.

Experimental Designs and Their Features

  • Between groups design:
    • Two or more separate groups; one receives treatment, others serve as controls.
    • Example: caffeine vs decaf; sometimes include a no-treatment group.
  • Within groups design (repeated measures):
    • All participants experience all conditions; measures taken before and after treatment.
    • Advantage: controls for individual differences; disadvantage: practice effects.
  • Mixed design:
    • Combines between and within aspects; two measurements (pre and post) across groups.
    • Allows both between-group and within-group comparisons.
  • Quasi-experimental designs:
    • Non-equivalent groups or interrupted time series without full random assignment.
    • Stronger threats to internal validity due to confounding group differences.

Randomization and Control of Confounds

  • Random assignment:
    • Equal chance of ending up in experimental or control group.
    • Cancels out individual differences (age, motivation, fatigue, etc.) across groups.
    • Essential for eliminating alternative causes (non-spuriousness).
  • Why not just randomize to a no-treatment group?
    • To control for placebo effects; use a placebo control (e.g., decaf coffee) to ensure equal experience across groups.
  • Placebo controls:
    • Placebo: an intervention with no active ingredient but with expected effect.
    • In psychology/medicine, helps isolate the effect of the active treatment from expectations.
  • Blinding:
    • Single blind: participants unaware of their group.
    • Double blind: both participants and experimenters unaware.
    • Triple blind: also analysts/data interpreters unaware.
    • In this study, double blind was used; there was also a test for blinding effectiveness (survey showing ~54% could guess correctly, near chance).

Baseline, Time, and Alternative Explanations

  • Baseline measurement:
    • A pre-treatment measurement to compare against post-treatment results.
    • Helps attribute changes to the treatment rather than pre-existing differences.
  • Potential confounds (examples discussed):
    • Sleep prior to lab, regular caffeine use, distraction, other substances, time of day, sugar in coffee, ADHD status, age, fatigue, motivation, etc.
  • Eliminating confounds:
    • Random assignment distributes confounds evenly.
    • Placebo control accounts for expectancy effects.
    • Blinding reduces biases in treatment administration and data interpretation.

Causation Framework in the Lab

  • Hypothesis testing form:
    • If caffeine increases alertness, then RT<em>extcaffeine<RT</em>extnocaffeine.RT<em>{ ext{caffeine}} < RT</em>{ ext{no caffeine}}.
  • Three criteria for causation:
    • Association: caffeine and faster reaction time should be related.
    • Temporal precedence: caffeine exposure precedes the faster reaction time.
    • Non-spuriousness: alternative explanations are ruled out (via randomization, placebo, blinding).
  • How the caffeine study fulfills (or falls short of) these:
    • Random assignment helps satisfy non-spuriousness by balancing confounds.
    • Placebo and blinding control for expectation effects.
    • A second control group (no drink) is quasi-experimental, introducing some uncertainty about causality for that group.

Practical Takeaways and Design Variants

  • True experiments are the gold standard for establishing causation when feasible, often labeled randomized controlled trials (RCTs).
  • Limitations of true experiments: ethical, practical, or cost constraints may prevent manipulation of certain variables.
  • Recognize variations:
    • Between groups: compare separate groups.
    • Within groups: compare the same participants across conditions with potential learning effects.
    • Mixed: combine both approaches to balance advantages.
  • Ethical note: not all variables can be manipulated; alternative designs are used to infer causal relationships where possible.

Quick Reference: Key Terminology

  • Association: correlation between A and B.
  • Causation: association + temporal precedence + non-spuriousness.
  • Random assignment: equal chance of group allocation; balances confounds.
  • Placebo effect: improvement due to expectations, not the active treatment.
  • Blinding: concealing group assignment to reduce bias; single/double/triple.
  • Between groups vs within groups vs mixed designs.
  • Baseline measurement: pre-treatment measure for comparison.
  • Gold standard: randomized, placebo-controlled, ideally double-blinded experiments.
  • Quasi-experiment: lacks full randomization; more vulnerable to confounds.
  • Interrupted time series: quasi analogue where measurements occur before and after an event.
  • Reaction time: a common dependent variable for alertness studies; lower is faster.